Nutra Pharma Corp (NPHC)

[skyway430]

Good morning all

Here is Rik’s response from my initial email asking about updates:

There’s not much to say that we haven’t already disclosed. The company is doing very well from an operational perspective: We have increasing online sales, opened up some new private label customers, we’ve launched new products, we’ve greatly increased our in-house manufacturing capabilities and re-certified our clean room for the production of our MS drug for the upcoming Phase II clinical study. We’re also working closely with the Defense Threat Reduction Agency (www.DTRA.mil) on our nerve agent counter-measure program and are seeking funding there.

We’ve been trying to come to a reasonable settlement with the SEC – but they are not reasonable. We believe that we will prevail in a trial, but it could take another year for this to see a courtroom. Our lawyers are working diligently in an attempt to settle the suit quickly and favorably.

We’ve also been trying to get the CE off of our symbol, but the OTC Markets does not seem to follow their own rules and does whatever they want. This issue is now in the hands of our attorneys as they try to get the CE off and the matter resolved.

The main issue – when it comes to share price – is just the CE designation. Our stock was almost back at a penny when they put the CE on our symbol. I have no doubt that we would be trading much higher if they had never put on that designation. As it is – most US brokerages will not trade a CE stock. We’ve been telling people to open accounts at T. Rowe Price, because they seem to be the only US broker that allows buying in Nutra Pharma. We’ve also had people buying in Canada and overseas (where they don’t seem to care about the CE).

Regardless, the company continues to grow and will be successful regardless of these obstacles.

$PMBY